Concentrix (CNXC) Cash & Equivalents (2020 - 2026)

Concentrix has reported Cash & Equivalents for 7 years, with the latest figure at $255.6 million in Q2 2026.

• Quarterly Cash & Equivalents fell 25.44% year-over-year to $255.6 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $255.6 million (down 25.44% YoY) and the FY2025 annual result came in at $327.3 million, up 36.07% from the prior year.
• Cash & Equivalents advanced to $255.6 million in Q2 2026 per CNXC's latest filing, from $222.7 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $2.1 billion in Q3 2023 and troughed at $142.2 million in Q1 2022.
• A 5-year average of $339.7 million and a median of $237.7 million in 2024 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2023 and 2024: Cash & Equivalents jumped 1099.89% in 2023, then slumped 88.35% in 2024.
• Over 5 years, Cash & Equivalents stood at $157.5 million in 2022, then soared by 87.56% to $295.3 million in 2023, then retreated by 18.54% to $240.6 million in 2024, then surged by 36.07% to $327.3 million in 2025, then retreated by 21.93% to $255.6 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $255.6 million, $222.7 million, and $327.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.